Four-week IgE/baseline IgE ratio combined with tryptase predicts clinical outcome in omalizumab-treated children with moderate-to-severe asthma
The aim of this study was to investigate the feasibility of the 4-week IgE/baseline IgE ratio and tryptase to predict the clinical efficacy of omalizumab in the treatment of pediatric moderate-to-severe asthma.
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-05-01
|
| Series: | Open Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/med-2025-1176 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The aim of this study was to investigate the feasibility of the 4-week IgE/baseline IgE ratio and tryptase to predict the clinical efficacy of omalizumab in the treatment of pediatric moderate-to-severe asthma. |
|---|---|
| ISSN: | 2391-5463 |